PDS Biotech CEO to Present at H.C. Wainwright Conference
PDS Biotech CEO to Present at H.C. Wainwright Conference
PRINCETON, N.J. – PDS Biotechnology Corporation (Nasdaq: PDSB), an innovative leader in immunotherapy, is set to make a significant appearance at the H.C. Wainwright 26th Annual Global Investment Conference. The event will take place from September 9-11, 2024. Frank Bedu-Addo, PhD, the Company’s President and CEO, will lead the presentation, focusing on exciting advancements in cancer treatment and vaccine development.
Conference Presentation Details
Below are the details of Dr. Bedu-Addo's presentation:
- Event: H.C. Wainwright 26th Annual Global Investment Conference
- Date: September 10, 2024
- Time: 2:00 - 2:30 PM ET
Those interested in attending the event can register for in-person attendance. The presentation will also be made available for on-demand viewing starting September 10, 2024, at 2:00 PM ET.
About PDS Biotechnology
PDS Biotechnology is revolutionizing cancer treatment through advanced immunotherapy. The company is particularly focused on enhancing immune response against infections and tumors. In 2024, PDS Biotech is planning to initiate a pivotal clinical trial for its leading program targeting advanced HPV16-positive head and neck squamous cell cancers. This innovative program combines its investigational immunotherapy, Versamune HPV, with immune checkpoint inhibitors, enhancing the therapeutic efficacy in challenging cancer cases.
Future Innovations and Goals
The upcoming trial is just one facet of PDS Biotech’s broader strategy, which includes the development of a combination therapy that features its IL-12 fused antibody drug conjugate, PDS01ADC. As the landscape of cancer therapies evolves, PDS Biotech is committed to staying at the forefront, ensuring that new treatment options are available to patients.
Contact and Media Inquiries
For further inquiries, PDS Biotech has established contacts for both investor and media relations:
Investor Contact:
Mike Moyer
LifeSci Advisors
Phone: +1 (617) 308-4306
Email: mmoyer@lifesciadvisors.com
Media Contact:
Gina Mangiaracina
6 Degrees
Phone: +1 (917) 797-7904
Email: gmangiaracina@6degreespr.com
Frequently Asked Questions
What is PDS Biotech's primary focus?
PDS Biotech focuses on immunotherapy aimed at treating cancers and developing vaccines for infectious diseases.
When will the CEO present at the conference?
The presentation is scheduled for September 10, 2024, from 2:00 to 2:30 PM ET.
How does PDS Biotech plan to advance cancer treatment?
The company aims to initiate a pivotal clinical trial to advance its lead program targeting HPV16-positive cancers.
What is Versamune?
Versamune is PDS Biotech’s investigational immunotherapy designed to enhance the immune system's ability to combat cancer.
How can I access the presentation after the event?
The presentation will be available for on-demand viewing on PDS Biotech’s website after the event concludes.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Education ERP Market Growth Projected to USD 75.84 Billion
- LIFT Expands Cali Property Significantly Through Strategic Staking
- Citi Predicts 125,000 Jobs in NFP, Foresees Fed Rate Cut
- Modest Predictive Growth in Canada Home Prices Amid Rate Cuts
- UK Home Prices Expected to Rise, Boosting First-Time Buyer Affordability
- Airlines Adjust Operations Amid Middle East Tensions
- UC Asset LP Announces Management-Driven Stock Buyback Plan
- Supermicro's CEO Expresses Confidence Amid Challenges
- Ukrenergo Board Members Resign Over Politically Motivated Dismissal
- US Dollar Index Emerges as Key Factor for European Markets
- Constellation Brands Adjusts Earnings Outlook for 2025
- Corporate Profit Challenges: Earnings Outlook for 2025
- Xiaohongshu Street Life Festival Draws Throngs and Creativity
- Bybit Powered by SATOS Launches Exclusive Trading Contest
- Heritage Environmental Services Welcomes Patrick Schultz as Chief Officer
- VSG Achieves Major Milestone with Coinstore Listing Today
- Bitcoin (BTC) Poised to Break $60,000 Barrier Soon
- QNB Corp. Successfully Completes $40 Million Subordinated Notes Offering
- Papaya Global Reinvents Payroll with Innovative Tech-First Solution
- DSCVR Celebrates 1 Million Unique Monthly Visitors Milestone
- Axiom Medical Welcomes Kevin Campbell as CFO to Lead Growth
- Real Estate Investment Trusts Drive Global Markets Upward
- Healthcare Digital Twins Market to Surge 25.70% Growth Rate
- VAST Resources Plc Announces Major Holdings Notification
- Charlamagne Tha God Supports Hope Center with Generous Donation
Recent Articles
- Airlines Adjust Operations Amid Middle East Tensions
- Xiaohongshu Street Life Festival Draws Throngs and Creativity
- Borregaard ASA Reports Managerial Transactions in Shares
- Trinity Biotech Welcomes Adrian Donohue as CCO
- Quantic School of Business Launches Advanced Degrees in Tech
- ChartPath and WoundZoom Partner to Revolutionize Wound Care
- VCI Global Secures $18 Million Contract for IPO Listings
- Alexandria Real Estate Equities Announces Q3 2024 Results Call
- LeNae Goolsby's Journey: Reversing Biological Age Naturally
- Cerro de Pasco Resources Completes Strategic Mine Sale
- Smart Meters Market Expected to Reach USD 49.35 Billion by 2031
- Sacks Parente Golf to Shine at H.C. Wainwright Conference
- Wyoming Rare Inc. Reports Exceptional Drill Results
- US Stock Futures Drop as Labor Data Week Begins
- Restaurant Brands International Inc. Launches Secure Notes Offering
- Invert Joins Toronto International Film Festival as Partner
- ATHA Energy's 2024 Exploration Uncovers New Mineral Trends
- Cheer Holding Unveils AI-Powered Series: Liaozhai Tales
- TransUnion CEO to Speak at Barclays Global Financial Conference
- Vitamins Market to Reach US$15.87 Billion by 2033
- Tesla's Humanoid Robots: A Game-Changer for the Future?
- Plastic Pigments Market Projected to Reach $22.5 Billion by 2032
- Enfinity Global Secures €190 Million for Solar Portfolio Expansion
- Markel Welcomes Rhys O'Neill as Senior Underwriter for Marine and Energy Liability
- AFL Publishes Financial Accounts in ESEF Xhtml Format